Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins

Biochemical Pharmacology

Volumn 53, Issue 9, 1997, Pages 1347-1355

  Belguendouz, Leila ^a   Fremont, Lucie ^a   Linard, Alain ^a  

^a CEMAGREF   (France)

Author keywords

Antioxidant; Flavonoids; Lipid peroxidation; Low density lipoprotein; Resveratrol; Wine polyphenols

Indexed keywords

ANTIOXIDANT; LOW DENSITY LIPOPROTEIN; RESVERATROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTIOXIDANT ACTIVITY; ARTICLE; CHELATION; DRUG EFFECT; ISOMERISM; LIPID ANALYSIS; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; ANTICARCINOGENIC AGENTS; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; STEREOISOMERISM; STILBENES; SWINE;

EID: 0030740237     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00820-9     Document Type: Article

References (41)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC and Witztum JL, Beyond cholesterol. N Engl J Med 320: 915-924, 1989.
2. Parthasarathy S and Rankin SM, Role of oxidized low density lipoprotein in atherogenesis. Prog Lipid Res 31: 127-143, 1992.
3. Esterbauer H, Striegl G, Puhl H and Rotheneder M, Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comms 6: 67-75, 1989.
4. Renaud S and de Lorgeril M, Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526, 1992.
5. Frankel EN, Kanner J, German JB, Parks E and Kinsella JE, Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet 341: 454-457, 1993.
6. Kondo K, Matsumoto A, Kurata H, Tanahashi H, Koda H, Amachi T and Itakura H, Inhibition of oxidation of low density lipoprotein with red wine. Lancet 344: 1152, 1994.
7. Frankel EN, Waterhouse AL and Teissedre PL, Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low density lipoproteins. J Agric Food Chem 43: 890-894, 1995.
8. Kimura Y, Ohminami H, Okuda H, Baba K, Kozawa M and Arichi S, Effects of stilbene components of roots of polygonum ssp. on liver injury in peroxidized oilfed rats. Planta Medica 49: 51-54, 1983.
9. Kimura Y, Okuda H and Arichi S, Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 834: 275-278, 1985.
10. Langcake P and Pryce RJ, The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 9: 77-86, 1976.
11. Jeandet P, Bessis R and Gautheron B, The production of resveratrol (3, 5, 4′-trihydroxystilbene) by grape berries in different developmental stages. Am J Enol Vitic 42: 41-46, 1991.
12. Jeandet P, Bessis R, Maume BF and Sbaghi M, Analysis of resveratrol in Burgundy wines. J Wine Res 4: 79-85, 1993.
13. Frankel EN, Waterhouse AL and Kinsella JE, Inhibition of human LDL oxidation by resveratrol. Lancet 341: 1103-1104, 1993.
14. Kuzuya M, Yamada K, Hayashi T, Funaki C, Naito M, Asai K and Kuzuya F, Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low density lipoprotein. Biochim Biophys Acta 1123: 339-341, 1992.
15. Esterbauer H and Jürgens G, Mechanistic and genetic aspects of susceptibility of LDL to oxidation. Curr Opin Lipidol 4: 114-124, 1993.
16. Chapman MJ, Animal lipoproteins: chemistry, structure, and comparative aspects. J Lipid Res 21: 789-853, 1980.
17. Jeandet P, Bessis R, Maume BF, Meunier P, Peyron D and Trollat P, Effect of enological practices on the resveratrol isomer content of wine. J Agric Food Chem 43: 316-319, 1995.
18. Mattivi F, Reniero F and Korhammer S, Isolation, characterization, and evolution in red wine vinification of resveratrol monomers. J Agric Food Chem 43: 1820-1823, 1995.
19. Havel RJ, Eder HA and Bragdon JH, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353, 1955.
20. Rumsey SC, Stucchi AF, Nicolosi RJ, Ginsberg HN, Ramakrishnan R and Deckelbaum RJ, Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys. J Lipid Res 35: 1592-1598, 1994.
21. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
22. Burton GW, Webb A and Ingold KU, A mild, rapid and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids 20: 29-39, 1985.
23. Wallin B and Camejo G, Lipoprotein oxidation and measurement of hydroperoxide formation in a single microtitre plate. Scand J Clin Lab Invest 54: 341-346, 1994.
24. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY and Jürgens G, A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30: 627-630, 1989.
25. Wallin B, Rosengren B, Shertzer HG and Camejo G, Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a simple microtiter plate: its use for evaluation of antioxidants. Anal Biochem 208: 10-15, 1993.
26. Knipping G, Rotheneder M, Striegl G and Esterbauer H, Antioxidants and resistance against oxidation of porcine LDL subfractions. J Lipid Res 31: 1965-1972, 1990.
27. 2+ mediated oxidative modification of low density lipoprotein. Biol Pharm Bull 17: 1567-1572, 1994.
28. Kleinveld HA, Hak-Lemmers HLM, Stalenhoef AFH and Demacker PNM, Improved measurement of low density lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low density lipoprotein. Clin Chem 38: 2066-2072, 1992.
29. Stocker R, Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin Lipidol 5: 422-433, 1994.
30. Vinson JA, Jang J, Dabbagh YA, Serry MM and Cai S, Plant polyphenols exhibit lipoprotein-bound antioxidant activity using an in vitro oxidation model for heart disease. J Agric Food Chem 43: 2798-2799, 1995.
31. Blond JP, Denis MP and Bezard J, Action antioxidante du resvératrol sur la lipoperoxidation. Sci Aliments 15: 347-358, 1995.
32. De Whalley CV, Rankin SM, Hoult JRS, Jessup W and Leake DS, Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 39: 1743-1750, 1990.
33. Mangiapane H, Thomson J, Salter A, Brown S, Duncan Bell G and White DA, The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occuring flavonoid. Biochem Pharmacol 43: 445-450, 1992.
34. 2+-mediated oxidative modification of low density lipoprotein. Biol Pharm Bull 18: 1-4, 1995.
35. Bors W, Heller W, Michel C and Saran M, Flavonoids as antioxidants: determination of radical scavenging efficiencies. Meth Enzymol 186: 343-355, 1990.
36. 2+-dependent oxidation of low density lipoproteins and its sensitivity to superoxide dismutase. Biochem Biophys Acta 1128: 50-57, 1992.
37. Kontush A, Hübner C, Finckh B, Kohlschütter A and Beisiegel U, Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein. Biochim Biophys Acta 1258: 177-187, 1995.
38. Bowry VW and Stocker R, Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low density lipoprotein. J Am Chem Soc 115: 6029-6044, 1993.
39. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G and Goldberg DM, The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235: 207-219, 1995.
40. Chen CK and Pace-Asciak CR, Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 27: 363-366, 1996.
41. Brune M, Rossander L and Hallberg L, Iron absorption and phenolic compound: Importance of different phenolic structures. Eur Clin Nutr 43: 547-558, 1989.